🇺🇸 FDA
Patent

US 11406663

Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use

granted A61KA61K33/244A61K9/0056

Quick answer

US patent 11406663 (Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use) held by UNICYCIVE THERAPEUTICS, INC. expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNICYCIVE THERAPEUTICS, INC.
Grant date
Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K33/244, A61K9/0056, A61K9/0095, A61K9/10